ERBB2 and gastric cancer: Six out of the 13 PDOs contained an EGFR or HER2 overexpression, frequently found in gastric cancer (The Cancer Genome Atlas Research Network, 2014), or pathogenic mutations in downstream members of the RTK/MAPK pathway (Table EV1).